Empagliflozin Linked to Higher Short-Term UTI Risk Than Dapagliflozin: Study Written By Dr Kartikeya Kohli2 Oct 2026 9:00 PM ISTEmpagliflozin was associated with a higher short-term incidence of urinary tract infections (UTIs) compared with dapagliflozin, despite similar...
NPPA Fixes Retail Prices of 11 Drugs Including Empagliflozin-Linagliptin-Metformin, Telmisartan-Amlodipine Combinations Written By Susmita Roy31 Aug 2026 8:15 PM ISTNew Delhi: In a fresh drug pricing move, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry...
NPPA Fixes Retail Prices for 39 New Drug Formulations Including Tenecteplase at Rs 60,238 Written By Farhat Nasim10 July 2026 2:28 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 39 new drug formulations under the provisions of the...
Empagliflozin Linked to Lower Risk of Advanced Kidney Disease Than Dapagliflozin in Stage 3 CKD: Study Written By Jacinthlyn Sylvia28 Jun 2026 8:15 PM ISTA new study published in the journal of BMC Nephrology showed that over the course of around 2.5 years of follow-up, patients with Stage 3 chronic...
Empagliflozin Shows Broader Metabolic Benefits over Sitagliptin, finds study Written By Dr Kartikeya Kohli3 Jun 2026 9:00 PM ISTA new study published in the journal of BMC Endocrine Disorders revealed that empagliflozin and sitagliptin improved metabolic and inflammatory...
NPPA Caps Prices of 30 Formulations Including Empagliflozin-Sitagliptin-Metformin,Vitamin D3 Products Written By Susmita Roy1 Jun 2026 7:15 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, Government of India, has fixed the...
SGLT2 Inhibitors Do Not Increase Appetite After Weight Stabilization: Study Written By Dr Kartikeya Kohli18 May 2026 10:00 AM ISTResearchers have found in a new study that sustained treatment with SGLT2 inhibitors does not lead to a compensatory increase in appetite after body...
Zydus Healthcare Asked to Revise Phase IV Protocol for Empagliflozin-Metformin Tablets Written By Susmita Roy5 April 2026 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has asked for revisions in the Phase IV...
Sitagliptin/Empagliflozin FDC Improves Glycaemic Control with Good Safety: Study Written By Dr. Shravani Dali3 April 2026 9:30 AM ISTResearchers have found in a new study that fixed-dose combination of sitagliptin and empagliflozin significantly improved glycaemic control at 24...
NPPA Fixes Retail Prices of 31 Drug Formulations Including Atorvastatin, Empagliflozin; Details Written By Susmita Roy28 March 2026 8:02 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of...
Empagliflozin Initiation in Hospital Benefits both new onset and acute decompensated HF Patients: Study Written By Jacinthlyn Sylvia17 March 2026 9:15 AM ISTA new study published in the journal of JACC: Heart Failure showed that despite a decreased diuretic response in patients with acute decompensated...
NPPA Fixes Retail Prices of 20 New Drug Formulations Under DPCO 2013 Written By Susmita Roy2 March 2026 1:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of...
